( 10) : 1439-1448．［10］FALAGAS M E，VOULOUMANOU E K，SAMONIS G，et al．Fosfomycin ［J］． Clin Microbiol Rev，2016，29( 2) : 321-347．［11］JIANG Y，SHEN P，WEI Z，et al． Dissemination of a clonecarrying a fosA3-harbouring plasmid mediates high fosfomycinresistance tate of KPC-producing Klebsiella pneumonia in China［J］． Int Antimicrob Agents，2015，45( 1) : 66-70．［12］DIEZ A M，MOROSINI M，TEDIM A P，et al． Antimicrobialactivity of fosfomycin-tobramycin combination against Pseudomonasaeruginosa isolates assessed by timekill assays and mutantprevention concentrations ［J］． Antimicrob Agents Chemother，2015，59( 10) : 6039-6045．［13］PETER G，CAROL A，DAVID ANDES，et al． Clinical practiceguidelines for the management of candidiasis: 2009 update by theInfectious Diseases Society of America ［J］． Clin Infect Dis，2009，48( 5) : 503-535．［14］杨莉莉，邓瑛，刘敏，等． 血浆( 1-3) -β-D 葡聚糖对侵袭性真菌感染诊断的临床意义［J］． 检验医学与临床，2016，13( 10) : 1364-1366．［15］WILLIAMSON D R，ALBERT M，HEELS-ANSDELL D，et al．Thrombocytopenia in critically ill patients receiving thrombopro-phylaxis: Frequency，risk factors，and outcomes ［J］． Chest，2013，144( 4) : 1207-1215．［16］吴骎，任建安． 外科感染合并血小板减少诊治进展［J］． 中国实用外科杂志，2016，36 ( 2) : 241-244．［17］STANWORTH S J，WALSH T S，PRESCOTT R J，et al．Thrombocytopenia and platelet transfusion in UK critical care: Amulticenter observational study ［J］． Transfusion，2013，53( 5) :1050-1058．［18］SINGH A， GOYAL M， SHARMA D． Thrombocytopenia inmalaria: Its usefulness in a clinical setting． A study from WesternRajasthan，India ［J］． Trop Doct，2014，44( 4) : 205-208．［19］DELLINGER R P，LEVY M M，RHODES A，et al． Survivingsepsis campaign:International guidelines for management ofsevere s...
